Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

London open: Assault on 6,000 begins

Thu, 23rd Dec 2010 08:15

Blue chips have had a first stab at hitting the magic 6,000 level following gains in the US overnight and are regrouping after falling just one point short.Insurer Old Mutual is among the early winners, followed by Sainsbury's and Kingfisher, but ARM is giving back a little of yesterday's big gains. Miners have also dipped and HSBC is off colour on fears about further monetary tightening measures in China.Oil prices closed above $90 a barrel for the first time since October 2008 yesterday following a bigger than expected decline in US crude supplies last week. That's giving BP and Royal Dutch Shell a lift this morning.Rio Tinto has increased its offer for Riversdale Mining to A$16 a share in cash, securing the backing of management for a deal worth A$3.9bn (£2.5bn). The mining giant admitted earlier this month it had talked to the Sydney-based firm, which has interests in African coal, about a A$15 a share takeover valuing the business at £2.2bn (A$3.5bn).Pharmaceuticals giants AstraZeneca and Abbott have dissolved their collaboration agreement covering the development of Certriad capsules. After the US FDA issued a Complete Response Letter for the Certriad new drug application the two companies decided that the resulting regulatory delay meant development of Certriad is no longer commercially attractive. Outsourcing giant Capita has announced two bolt-on acquisitions. It is buying hotel and meetings bookings firm BSI for £42.5m, and ICT services provider SunGard Public Sector Holdings for £86m.

Related Shares

More News
20 Jun 2024 10:56

TOP NEWS: AstraZeneca's Truqap gets OK from EU for breast cancer form

(Alliance News) - AstraZeneca PLC on Thursday said that the EU approved its prescription medicine Truqap, in combination with hormonal therapy Faslode...

18 Jun 2024 09:33

TOP NEWS: AstraZeneca disappointed by breast cancer drug trial results

(Alliance News) - AstraZeneca PLC on Tuesday said findings from a breast cancer drug trial showed that Truqap did not meet its primary endpoints.

18 Jun 2024 07:51

LONDON BRIEFING: Ashtead profit declines; Whitbread sales rise

(Alliance News) - London's FTSE 100 is called to open higher on Tuesday, taking confidence from a decent showing for US equities overnight, with infla...

18 Jun 2024 07:17

AstraZeneca trial fails to treat 'challenging' breast cancer

(Sharecast News) - AstraZeneca announced on Tuesday that the phase three 'CAPItello-290' trial for 'Truqap', or capivasertib, in combination with pacl...

17 Jun 2024 09:09

TOP NEWS: Astra's Imfinzi plus chemo approved for cancer form in US

(Alliance News) - AstraZeneca PLC on Monday said it secured a new US approval for cancer treatment Imfinzi, also known as durvalumab, hailing an "impo...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.